ICM
XPER icon

Invenomic Capital Management’s Xperi XPER Stock Holding History

Invenomic Capital Management’s Portfolio XPER Stock Details XPER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-247,955
Closed -$1.96M – 184
2025
Q2 		$1.96M Buy
+247,955
New +$1.87M 0.11% 136

Other funds holding XPER

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invenomic Capital Management's XPER Position: Q3 2025 in Review

Invenomic Capital Management sold out of Xperi (XPER) in Q3 2025, closing a stake of 247,955 shares — an estimated $1.96M sold.

Invenomic Capital Management first reported a position in XPER in Q2 2025 and held it in 1 quarter. The position peaked at $1.96M in Q2 2025. 143 funds tracked by Wall St. Rank hold XPER as of Q3 2025.

  • Invenomic Capital Management reported no remaining Xperi position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 247,955 Xperi shares in Q3 2025, an estimated $1.96M.
  • Invenomic Capital Management first reported a position in Xperi in Q2 2025 and held it in 1 quarter.
  • Invenomic Capital Management's Xperi position peaked at $1.96M in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Xperi as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.